• Mutual Funds
  • HDFC Mutual Fund
  • HDFC Pharma And Healthcare Fund Regular Growth
HDFC Mutual Funds

HDFC Pharma And Healthcare Fund Regular Plan Growth

EquitySectoral / Thematic - Pharma And Healthcare

16.517

NAV (Oct 15)

61.988%
Till Date CAGR
Scripbox Opinion
Not Reviewed yet
Our analysis of this fundLearn how we rate funds ->
Scripbox Recommended Equity Funds
Want the equity funds that are right for your long term equity investment needs?Learn more

Investment Calculator

Investment Duration5 years

0

Total Investment

0

Wealth Gained

0

Total Corpus Created (₹)

With CAGR of 11.25 % in 5 years

Historical NAV

16.517

NAV (Oct 15)

Fund Returns

Last 1Y
63.2%
Last 3Y
NA
Last 5Y
NA
Last 10Y
NA
Since Inception
62%
6 Month CAGR
32.7%

Scheme Information

Investment Objective

The scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.

Expense Ratio
2.24
Launched (0y ago)
2.24
AUM in Crores
1302.7
ISIN
INF179KC1HL7
Lock-in
-
Benchmark
BSE Healthcare Index
SIP Minimum
1000
Lumpsum Min.
5000
Standard Deviation (3yr)
-
Standard Deviation
-
Beta
-
Sharpe Ratio
-
YTM
-
Fund Managers

Dhruv Muchhal

Fund Manager

Nikhil Mathur

Fund Manager

Important Links

Scheme Information Document

Statement of Additional Information

Portfolio Disclosure

Returns Calculator Comparison

of

for

with step up of

AssetReturnsTotal CorpusGainsCAGR
HDFC Pharma And Healthcare Fund (G)70%45,66,214 38,33,60263.2%
EPF70% 9,00,761 1,68,1498.50%
Property70% 8,67,662 1,35,0507.00%
PPF70% 8,69,819 1,37,2077.10%
Bank FD70% 8,46,471 1,13,8596.00%
Gold70% 8,46,471 1,13,8596.00%
Savings Bank70% 8,25,950 93,3385.00%

Disclaimer: Products compared like fixed deposits may provide fixed guaranteed returns. Mutual Funds investments are subject to market risk, read all scheme related documents carefully before investing. Past performance is not an indicator of future returns.

Asset allocation and Holdings

Last updated on 2023-12-28

Top Stock Holdings

Sun Pharmaceutical Industries Ltd.

12.5%
12.46%

Divi's Laboratories Ltd.

7.6%
7.56%

Dr. Reddy's Laboratories Ltd.

5.9%
5.89%

Cipla Ltd.

5.9%
5.87%

Lupin Ltd.

5.1%
5.12%
See all holdings

Allocation by Sector

Healthcare

99.5%
99.45%
See all sectors

Comparison with Equity Funds

Fund NameFund Size
mirae-asset-global
Mirae Asset ELSS Tax Saver Fund (G)

₹ 26,417 cr

₹ 24,508 cr

₹ 66,206 cr

₹ 51,197 cr

₹ 17,770 cr

amc-img

About the AMC

HDFC Mutual Fund

HDFC Asset Management Company was started in the year 1999. Initially it was setup as a joint venture between HDFC and Standard Life Investment Limited (SLI) but subsequently thereafter in August 2018 it carried out its first public offering and became a puclic listed company. The Compnay presently has about 210 branches countrywide and about 70 thousand empaneled distribution networks.amc-img
phone-img022 – 66316333
email-imgshareholders.relations@hdfcfund.com
Fund NameScripbox Opinion
Till Date CAGR

5.7%

5.9%

15.2%

6.7%

20.6%

13.3%

6.5%

7.8%

6%

8.1%

HDFC Pharma And Healthcare Fund Regular Plan Growth Review

HDFC Pharma And Healthcare Fund Regular Plan Growth is a Sectoral / Thematic - Pharma And Healthcare Equity fund and has delivered an annualised return of 61.988% over a period of 1 years. The fund is managed by HDFC Mutual Fund. The fund managers are Dhruv Muchhal, Nikhil Mathur.

Nav of HDFC Pharma And Healthcare Fund as of 10/15/2024 is ₹16.52 with the total AUM as of 10/16/2024 is ₹1302.6738. With Scripbox you can compare and check the latest nav for all mutual funds in India. HDFC Pharma And Healthcare Fund was launched on 2023-10-04. The category risk of the fund is null.

The minimum SIP amount for HDFC Pharma And Healthcare Fund Regular Plan Growth is ₹1000 and you can increase this in multiples of ₹100. In case you want to invest a lump sum, the minimum amount to be invested is ₹5000. Check your estimated returns on mutual funds by using sip calculator.

HDFC Pharma And Healthcare Fund Regular Growth is meant for investors with a minimum investment horizon of 5-7 years. Due to the asset class nature, expect volatility in your investments over the short term. The fund is benchmarked to BSE Healthcare Index.

It is rated as a null fund in Equity and delivered 63.234% returns in the last 1 year. Scripbox provides a compare mutual funds research tool to view a detailed comparison with HDFC Pharma And Healthcare Fund.

Frequently Asked Questions

What is HDFC Pharma And Healthcare Fund?

It is a Sectoral / Thematic - Pharma And Healthcare Equity scheme predominantly investing across Equity instruments with an investment objective to generate wealth over the long term.

How to invest in HDFC Pharma And Healthcare Fund?

You can invest in HDFC Pharma And Healthcare Fund Regular Plan through AMC, intermediaries, brokers or platforms like Scripbox. To learn step by step process visit how to invest in mutual funds?

What is the minimum sip amount of HDFC Pharma And Healthcare Fund?

The minimum sip amount for HDFC Pharma And Healthcare Fund Regular Plan is ₹1000. You can invest in multiples of ₹5000.

Is HDFC Pharma And Healthcare Fund Regular Plan good to invest in?

As per Scripbox experts, it is a fund. You can invest in it if its investment objective and risk-o-meter matches your investment goals and risk preferences.

What is the expense ratio of the HDFC Pharma And Healthcare Fund Regular Plan Growth?

The expense ratio of the HDFC Pharma And Healthcare Fund Regular Growth is 2.24% for regular plan.

What is the NAV of HDFC Pharma And Healthcare Fund?

Today's HDFC Pharma And Healthcare Fund Regular Growth NAV is ₹16.52.